Aminoglycoside antibiotics are commonly used in the treatment of bacterial infections 28 in human and veterinary practice. Because of their toxicity, the European Community has established Maximum Residue Limits (MRL) in foodstuffs of animal origin (EEC 30 No 2377/90). In the present work the performance of two new enzyme immunoassays (EIA), I'screen Gentamicin and I'screen Neomycin, for the quantitative detection of the 32 aminoglycosides gentamicin and neomycin in milk and tissue are described. The validation of these EIAs has been performed in accordance to criteria of the European 34 Decision 657/2002. Assays sensitivity at the MRLs was 95% for milk samples and 100% for tissue samples, while specificity was 100% at 33% and 25% of the MRLs for 36 milk and tissues, respectively. The performance of these EIAs indicates that they can be used as easy screening methods in the analysis of aminoglycosides in milk and tissue 38 samples.
The aminoglycosides are closely-related antibiotics produced by Streptomyces spp. and In food-animal production, the most commonly used aminoglycosides are gentamicin, neomycin, streptomycin and dihydrostreptomycin. Since 1970 EU Directives regulated 52 the use of antibiotics as additives in feed (Council Directive 70/524 EEC and following amendments), progressively banning the use of these molecules for auxinic purposes. 54 Aminoglycosides, intended as therapeutics, are preferably administered by injection. In this case, they accumulate in tissues in high and persistent residues. In fact, since they 56 are eliminated by renal filtration, they tend to accumulate in the kidney where they bind to tissue proteins and macromolecules via ionic bonds (Isoherranen and Soback 1999), 58 causing nephrotoxicity (Salisbury 1995). Besides urines and kidney, aminoglycosides can be found in cochlea, in serum, in milk and in other tissues, depending on plasma 60 levels. Antibiotic levels in milk are dependent on a number of physico-chemical parameters, and their concentration is higher in cases of mastitis (Debackere 1995; 62 Saran 1995), following intramammary treatment. 64 For humans, aminoglycosides in food hold the risk of undesirable health effects, as nephrotoxicity and ototoxicity (Saran 1995 Maximum Residue Limits (MRLs) of veterinary drugs in foodstuffs of animal origin. 68 The wide use of aminoglycosides in veterinary medicine requires therefore suitable screening and confirmatory methods for their detection in edible tissues. For the 70 detection of aminoglycosides in food, microbial inhibition assays are widely used as screening methods (Schenck 1998), but even if they are simple and relatively cheap, 72 they are time consuming, lack sensitivity (Isoherranen and Soback 1999) and do not allow substance identification. On the other hand, chromatographic analysis (LC/MS), 74 is used as confirmatory method (Salisbury 1995), because it provides unequivocal identification of the analyte and is aimed at preventing false positive results (Woodward 76 1995), but it is rather expensive. 78 In recent years, many enzyme immunoassays (EIA) for the detection of aminoglycoside thanks to their ease of use, sensitivity, rapidity and specificity. Nevertheless, the sensitivity and specificity of quantitative EIA kits for gentamicin and neomycin 84 detection do not always fit with the EU MRLs for these two antibiotics. 86 The present work describes the performance evaluation of two new quantitative enzyme immunoassays for the detection of gentamicin and neomycin in milk and tissues, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Test samples
Twenty raw milk samples, derived from untreated cows, were kind gifts from AAFVG 110 (Associazione Allevatori del Friuli Venezia Giulia). Twenty tissue samples (ten bovine and ten swine muscles) were purchased in a supermarket, guaranteed as residue free 112 ("Prodotti con Amore", COOP Italia).
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Gentamicin EIA
The anti-gentamicin antibody was raised in rabbit by three cycles of immunization with 116 gentamicin-BSA conjugates, obtained using EDC and Sulpho-NHS (Hermanson 1996). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The anti-neomycin antibody was raised in rabbit by three cycles of immunization with neomycin-BSA conjugates, obtained using EDC and Sulpho-NHS (Hermanson 1996). 144 Microtiter plates were coated with anti-neomycin antibodies purified on a Protein A Sepharose CL-4B column. As the gentamicin assay, the I'screen Neomycin test kit is a 146 competitive enzyme immunoassay. The assay is carried out in the same way, except that the first incubation is for 20 min and the second for 10 min. Data handling was also 148 performed with the same instrument, the same software, the same curve fitting. Also in this case two different calibration curves for the analysis of milk or meat samples were 150 used, but both curves were freshly prepared at each analysis.
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Cross-reactivities determination
Calibration curves of different aminoglycosides antibiotics (gentamicin, neomycin, 154 streptomycin, kanamicin) were prepared using the test kit dilution buffers. The crossreactivities values were calculated from the calibration curves obtained, according to the for the buffer calibration curve and 5-250 µg L -1 for the milk calibration curve. Since sample preparation procedures determine a ten folds dilution factor, these calibration 194 curves allow the analysis of samples contaminated with amounts of gentamicin in the range of 25-2500 µg kg -1 for tissue and 50-2500 µg L -1 for milk. Therefore CVs, evaluated in three runs, were below 10% in between 5 and 100 µg L -1 , both for milk and buffer standard solutions. 204 The gentamicin EIA is highly specific, since cross reactivities against other 206 aminoglycosides (neomycin, streptomycin, kanamycin) are below 0.1%. It is stable after storage at +4°C for 1 year, since after incubation of the kit at 37°C for 1 week, assay 208 performances (OD values and calibration curve IC 50 ) are not significantly changed (data not shown) (Deshpande 1996).
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I'screen Neomycin. Figure 2 shows buffer and milk calibration curves obtained for 212 neomycin assay (mean of 10 runs) and Table II summarizes their parameters. As for the gentamicin assay, the milk calibration curve is necessary to compensate matrix effect of 214 milk samples, while tissue samples can be analysed using a buffer calibration curve.
The values obtained for LODs, IC 50 , slope and R 2 show also for this assay a high quality 216 of calibration, as well as a high repeatability of results in case of buffer calibration, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 the range of 100-10 000 µg kg -1 in tissue and 500-10 000 µg L -1 in milk. The use of two different calibration curves allows therefore the identification of samples contaminated 228 with levels of antibiotic around MRLs; moreover, MRLs were in both cases in the linear part of the calibration curves. 230 The intra-assay precision of I'screen Neomycin was determined testing the standard 232 solutions with three duplicates. CVs of the mean absorbance were always < 10%. The intra-assay dose CV testing buffer standard solutions was below 10% in between 10 and 234 100 ng/ml. The intra-assay dose CV testing milk standard solutions was below 5% in between 100 and 500 µg L -1 . Dose inter-assay CVs, evaluated in three different 236 experiments, were less than 15% for buffer standard solutions and less than 20% for milk standard solutions. 238 The specificity of the assay was studied by testing other aminoglycoside antibiotics 240 (gentamicin, streptomycin, kanamycin): cross-reactivities were in all cases below 0.1%.
The stability of the reagents was evaluated incubating the test kit at 37°C for one week: 242 Sensitivity evaluated at MRL contamination values for both kits was 95% (5% β error).
The detection capabilities (CCβ) were therefore 100 µg kg -1 for I'screen Gentamicin 278 and 1500 µg kg -1 for I'screen Neomycin. It can be concluded that both assays had a good diagnostic specificity and a high sensitivity at the MRL. Mean recovery at the MRL was 128±14% for gentamicin and 132±22% for neomycin.
Both assays overestimated the true content of analyte, particularly in the lower part of 292 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 obtain high recoveries of analytes. This method was applied in the analysis of twenty blank muscle samples (ten bovine and ten swine). 314 The limits of decision and the detection capabilities were established as for milk testing. 316 Table IV shows B/B 0 %, and α and β errors for both kits. Evaluating the blank muscle Accuracy in tissue testing was evaluated in the range 100-1000 µg kg -1 for neomycin 326 and in the range 50-500 µg kg -1 for gentamicin. The correlations between spiked and measured concentration were quite good for both analytes (r 2 > 0.95). The slope was 328 close to 1 in case of gentamicin, lower in case of neomycin (see Figure 4 ). S y.x values were also quite low: 27.78 and 46.66 µg kg -1 for gentamicin and neomycin, 330 respectively. In case of gentamicin the recovery at the MRL was 160±40%, in case of neomycin it was 94 ± 9%. [Insert Figure 4 about here] 332 The precision of I'screen Gentamicin and I'screen Neomycin assays in tissue testing 334 was studied analysing three times the same fortified muscle sample. Gentamicin was spiked at MRL (50 µg kg -1 ) and 2 MRL (100 µg kg -1 ), obtaining intra assay CVs (n=3 336 duplicates) of 5.35 and 6.84%, respectively and inter-assay CVs (n=3 days) of 12.33 and 14.56%, respectively. In the same way neomycin was spiked at MRL (500 µg kg -1 ) 338 and 2 MRL (1000 µg kg -1 ): intra-assay CVs were 10.44 and 5.51%, respectively and inter-assay CVs were 16.39 and 15.58%, respectively. The use of two different calibration curves in the analysis of milk or tissue samples and 410 a moderate dilution factor contribute to the accuracy of the assays, which, at the MRL level, was in the range between 94% and 160%. 412 Taking into account the matrices tested and the procedures of their preparation, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Two different calibration curves were applied depending on the samples: the milk standard curve in case of milk and the buffer standard curve in case of tissue. Figure 2 . I'screen Neomycin EIA calibration curves (mean ± SD, n=10).
Two different calibration curves were applied depending on the samples: the milk standard curve in case of milk and the buffer standard curve in case of tissue. Figure 3 . Recoveries studies to assess the accuracy of milk samples testing (mean ± SD, n=20). Figure 4 . Recoveries studies to assess the accuracy of muscle samples testing (mean ± SD, n=20). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
